Comment on: Effectiveness and safety of anti-tau drugs for Alzheimer's disease.

J Am Geriatr Soc

TauRx Pharmaceuticals Ltd., Aberdeen, UK.

Published: July 2023

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgs.18351DOI Listing

Publication Analysis

Top Keywords

comment effectiveness
4
effectiveness safety
4
safety anti-tau
4
anti-tau drugs
4
drugs alzheimer's
4
alzheimer's disease
4
comment
1
safety
1
anti-tau
1
drugs
1

Similar Publications

Article Synopsis
  • The creation of sustainable food systems is complex and involves various interconnected issues, making it a "wicked problem."
  • There is no single solution that applies universally; different approaches may be needed based on local contexts and challenges.
  • Addressing this issue requires collaboration among diverse stakeholders to foster innovative and adaptable strategies.
View Article and Find Full Text PDF

Description This letter to the editor addresses limitations to holding COVID vaccines responsible for the diagnosis of thrombotic thrombocytopenic purpura and discusses the potential differential diagnoses that must be considered.

View Article and Find Full Text PDF

A well-balanced ion channel trafficking machinery is paramount for the normal electromechanical function of the heart. Ion channel variants and many drugs can alter the cardiac action potential and lead to arrhythmias by interfering with mechanisms like ion channel synthesis, trafficking, gating, permeation, and recycling. A case in point is the Long QT syndrome (LQTS), a highly arrhythmogenic disease characterized by an abnormally prolonged QT interval on ECG produced by variants and drugs that interfere with the action potential.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!